Understanding the Impact of Drug Shortages on Oncology Care Delivery
NCT03953027 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-04-04
Summary
This trial studies the impact of drug shortages on oncology care delivery. Gathering information about cancer drug shortages over time may help researchers improve access to drugs during times of shortages.
Conditions
- Community Practice
- Staff
Interventions
- OTHER
-
Survey Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Rochester NCORP Research Base
lead OTHER
Principal Investigators
-
Elaine Hill, PhD · University of Rochester NCORP Research Base
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2025-06-01
- Completion
- 2025-06-18
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
NCT03459729 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
NCT00387504 ·Status: COMPLETED ·Phase: PHASE1
-
Analyses of Human Samples Collected in Clinical Trials
NCT00339664 ·Status: COMPLETED
-
Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
NCT01934335 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of a Mediterranean Diet Intervention on Cancer-related Fatigue and Mitochondrial Function During Chemotherapy
NCT04534738 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors
NCT03257969 ·Status: RECRUITING ·Phase: NA
-
Fenretinide in Treating Patients With Solid Tumors
NCT00003250 ·Status: COMPLETED ·Phase: PHASE1
-
Screening of Cancer Patients to Assess Impact of COVID-19
NCT04373005 ·Status: TERMINATED
-
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy
NCT00486304 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
NCT04803305 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841
NCT06219499 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
NCT02210182 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication
NCT03104114 ·Status: COMPLETED ·Phase: NA
-
The Drug Rediscovery Protocol (DRUP Trial)
NCT02925234 ·Status: RECRUITING ·Phase: PHASE2
-
Preparatory Work to Assess Adherence to Oral Chemotherapy
NCT02895542 ·Status: COMPLETED
-
Food Effect Study of D-0502 Tablet in Healthy Volunteers
NCT03810625 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients
NCT00728468 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
NCT01048983 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
NCT00365261 ·Status: COMPLETED ·Phase: PHASE4
-
A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers
NCT01034748 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenomic Testing to Personalize Supportive Oncology
NCT04500301 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
NCT03997370 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Acetylamantadine Excretion by Cancer Patients
NCT02277938 ·Status: UNKNOWN
-
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy
NCT04327583 ·Status: UNKNOWN ·Phase: NA
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED